Company Overview and News

1
128 Monthly Pay Small/Mid/Large Cap Equities Show 3.6%-17.52% Yields; 62 Funds Yield 6.15%-19.5%

2018-04-16 seekingalpha
Contents: 1. US/CDN Stocks @3.58%+ yield (128) 2. Stocks by price upside (30); 3. Closed-End Investment Companies, Exchange-Traded Funds & Notes (CEICs/ETFs/ETNs) @6.15%+ yield (62).
Upvote Downvote

 
TransAlta's (TAC) CEO Dawn Farrell on Q4 2017 Results - Earnings Call Transcript

2018-03-03 seekingalpha
Good morning ladies and gentlemen, thank you for standing by. Welcome to the TransAlta Corporation Fourth Quarter and Full Year 2017 Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be question-and-answer session. [Operator Instructions] As a reminder, this conference call is being broadcast live on the internet and recorded.
Upvote Downvote

 
BRIEF-Transalta Renewables Acquires Two U.S. Wind Projects

2018-02-20 reuters
* TRANSALTA RENEWABLES INC - ‍TOTAL COST OF 2 PROJECTS IS ESTIMATED TO BE $240 MILLION, OF WHICH APPROXIMATELY 70% WILL BE FUNDED IN 2018, REMAINDER IN 2019​
Upvote Downvote

1
Should You Buy This 7% Yielding Utility Company?

2018-01-12 seekingalpha
TransAlta Renewable has a diversified portfolio of clean and renewable power generators in Canada, the U.S. and Australia Killam’s.
Upvote Downvote

3
Dividend Sensei Positions For 2018: Something Is Always On Sale

2018-01-03 seekingalpha
My goal is to generate maximum safe yield, with fast dividend growth, and buy stocks at their most undervalued.
Upvote Downvote

 
'Safer' Dividend S-M-L MoPay Gains Are By 6 REITS, 2 Financials, 1 Health, 1 Utility To 12/19/18

2017-12-22 seekingalpha
32 of 106 Monthly Paying (MoPay) Small-Mid-Large Cap US & Canadian Dividend stocks were tagged "safer" by showing positive annual-returns, and free cash-flow-yields greater than their dividend-yields as of 12/19/17.
Upvote Downvote

1
Dividend Sensei's Portfolio Update 14: Want To Retire Rich? Then Choose Your Next Car Carefully

2017-12-19 seekingalpha
My sister's new used car is a great example of how becoming rich isn't just luck, but includes important lifestyle choices.
Upvote Downvote

 
Onex-backed Canadian renewables firm Pinnacle files for IPO

2017-12-19 reuters
Dec 18 (Reuters) - Pinnacle Renewable Energy Inc, a wood pellets producer owned by Canadian private equity firm Onex Corp , said on Monday it has filed a preliminary prospectus with the Toronto Stock Exchange for an initial public offering of its common shares.
Upvote Downvote

 
Today’s Free Reports Brookfield Renewable Partners, TransAlta Renewables, Boralex, and Northland Power

2017-12-18 accesswire
LONDON, UK / ACCESSWIRE / December 18, 2017 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Utilities - Independent Power Producers industry: Brookfield Renewable Partners, TransAlta Renewables, Boralex, and Northland Power. Access our complimentary up-to-the-minute research reports by becoming an online member now:
Upvote Downvote

 
Onex-backed Canadian renewables firm Pinnacle set to list -sources

2017-12-15 reuters
TORONTO (Reuters) - Wood pellets producer Pinnacle Renewable Energy Inc, owned by Canadian private equity firm Onex Corp (ONEX.TO), wants to raise about C$175 million ($136 million) through a Toronto initial public offering (IPO), people familiar with the matter told Reuters this week.
Upvote Downvote

1
The 1 High-Yielding Midstream To Avoid (And 4 To Buy)

2017-12-14 seekingalpha
Altagas delivered good third quarter numbers and some metrics suggest that it is the cheapest of the Canadian midstream companies.
Upvote Downvote

 
The One High Yielding Midstream To Avoid (And Four To Buy)

2017-12-14 seekingalpha
Altagas delivered good third quarter numbers and some metrics suggest that it is the cheapest of the Canadian midstream companies.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...